Two anti-cancer medicament raw material compounds
A technology of anti-cancer drugs and compounds, applied in 5 fields, to achieve the effect of inducing tumor cell apoptosis and inhibiting growth in vivo
Inactive Publication Date: 2008-07-09
张南
View PDF0 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Data show that 3,3',4',5,6,7,8-heptamethoxyflavone inhibits P-glycoprotein-mediated export of [3H]vincristine, leading to intracellular accumulation of chemotherapeutic drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0040] In order to prove the medicinal effect of the raw material compound of the present invention, the following methods can be used to verify:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention belongs to the chemical medicine field, in particular to two anti-cancer medicine raw material compounds. The invention synthesizes several chemical raw materials to obtain novel 3- methoxy flavoine derivative-compound 5, 7-dihydroxy-8-(1, 1-dimethylaniline-3, 3', 4'- 3-methoxyflavone and compound 5, 7-dihydroxy-8-(1, 1-dimethylaniline-3, 4'- 2-methoxyflavone in four steps. The two compounds can reach the level of poly-methoxyl flavones (PMFS) compound which is separated from natural plants and poly-methylation flavones C-glycosylated derivative which are separated from medical plants, which have equal role and effect of inhibiting human tumor generation, play positive inhibition in anti-inflammatory diseases and anti-atherosclerosis diseases, and are two important raw materials of wide-spectrum antineoplastic medicines.
Description
Technical field: [0001] The invention belongs to the field of chemical medicines, in particular to two anticancer drug raw material compounds 5,7-dihydroxy-8-(1,1-dimethylaniline)-3,3',4'-trimethoxyflavone, and 5,7-Dihydroxy-8-(1,1-dimethylaniline)-3,4'-dimethoxyflavone. Background technique: [0002] 3-Methoxyflavones belong to polymethoxyflavonoids (PMFs) isolated from citrus plants. Due to their broad-spectrum biological activities including anti-inflammatory, anti-cancer and anti-atherosclerosis, they have been received special attention. There is growing interest in exploring the health properties of PMFs in citrus fruit. Therefore, the isolation and identification of PMFs from sweet orange peel will enable new applications of by-products of orange juice processing, as well as the consumption of oranges in other health products and pharmaceuticals. [0003] PMFs achieve their anticancer effects through different potential mechanisms. 3,3',4',5,6,7,8-heptamethoxyflav...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): C07D311/28A61K31/353A61P35/00
Inventor 张南
Owner 张南
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com